MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6554
+0.0505
+8.35%
Opening 12:38 05/24 EDT
OPEN
0.6100
PREV CLOSE
0.6049
HIGH
0.7000
LOW
0.6100
VOLUME
32.07K
TURNOVER
12.36K
52 WEEK HIGH
5.39
52 WEEK LOW
0.5488
MARKET CAP
6.91M
P/E (TTM)
-0.2092
1D
5D
1M
3M
1Y
5Y
BRIEF-Nuwellis Inc Announces Adjournment Of Annual Meeting Of Stockholders Due To Lack Of Quorum
reuters.com · 6d ago
Nuwellis, Inc. Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum
MINNEAPOLIS, May 17, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that the Company’s 2022 Annual Meeting of Stockholders, on May 17, 2022 at 2:00 p.m., was convened and adjourned, without any business being conducted, due to lack...
GlobeNewswire · 6d ago
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 807 companies reached new 52-week lows.
Benzinga · 05/11 16:28
Nuwellis GAAP EPS of -$0.42 beats by $0.01, revenue of $1.9M beats by $0.11M
Nuwellis press release (NASDAQ:NUWE): Q1 GAAP EPS of -$0.42 beats by $0.01. Revenue of $1.9M (flat Y/Y) beats by $0.11M. Shares were trading +4.01% pre-market.
Seekingalpha · 05/10 13:16
Nuwellis: Q1 Earnings Insights
  Nuwellis (NASDAQ:NUWE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Benzinga · 05/10 13:01
Nuwellis Q1 EPS $(0.42) Beats $(0.46) Estimate, Sales $1.90M Beat $1.79M Estimate
Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.46) by 8.7 percent. This is a 66.4 percent increase over losses of $(1.25) per share from the same
Benzinga · 05/10 12:14
Earnings Scheduled For May 10, 2022
  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Benzinga · 05/10 09:18
-- Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.9M, vs. Street Est of $1.79M
MT Newswires · 05/10 08:09
More
No Data
Learn about the latest financial forecast of NUWE. Analyze the recent business situations of Nuwellis Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
66.67%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NUWE stock price target is 4.667 with a high estimate of 6.00 and a low estimate of 2.500.
High6.00
Average4.667
Low2.500
Current 0.6554
EPS
Actual
Estimate
-0.71-0.53-0.36-0.18
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 25
Institutional Holdings: 1.30M
% Owned: 12.33%
Shares Outstanding: 10.54M
TypeInstitutionsShares
Increased
6
54.79K
New
3
101.96K
Decreased
2
9.21K
Sold Out
8
1.33M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-1.13%
Healthcare Equipment & Supplies
-1.40%
Key Executives
Chairman/Director
John Erb
President/Chief Executive Officer
Nestor Jaramillo
Chief Financial Officer
George Montague
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Neil Ayotte
Chief Accounting Officer/Controller
Paul Wotta
Lead Director/Independent Director
Warren Watson
Independent Director
Steven Brandt
Independent Director
Maria Costanzo
Independent Director
Jon Salveson
Independent Director
Gregory Waller
No Data
No Data
About NUWE
Nuwellis, Inc., formerly CHF Solutions, Inc., is a medical device company. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow system for ultrafiltration therapy that gently removes fluid and restores balance to patients suffering from fluid overload. The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System consists of three components: the console, which allows caregivers control of ultrafiltration therapy; the peripheral catheter draws blood from and returns blood to the patient, and the blood circuit set that filters the patient’s blood and collects excess water and salt. Its solutions also include RenalSense Clarity RMS, which is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff.

Webull offers kinds of Nuwellis Inc stock information, including NASDAQ:NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.